Communicable and Environmental Diseases and Emergency Preparedness 2010-2012 Annual Report Communicable and Environmental Disease Services Tennessee Department of Health 1st Floor, Cordell Hull Building 425 5th Avenue North Nashville, Tennessee 37243 Phone 615-741-7247 (24 hours a day/7 days a week) Toll-Free 800-404-3006 Fax 615-741-3857 Communicable and Environmental Diseases and Emergency Preparedness Annual Report Tennessee Department of Health Communicable and Environmental Diseases and Emergency Preparedness John Dreyzehner, MD, MPH, FACOEM, Commissioner of Health David Reagan, MD, PhD, Chief Medical Officer Timothy F. Jones, MD, State Epidemiologist, Director, Communicable and Environmental Diseases and Emergency Preparedness Available electronically at the Tennessee Department of Health website. In the search box in the top right-hand corner, type “CEDEP Annual Report” and hit Enter. Under Search Results, click on the result entitled “CEDEP Reports”. http://www.tn.gov/health This report reflects the contributions of the many committed professionals who are part of the Communicable and Environmental Disease Services Section, Tennessee Department of Health. iii Communicable and Environmental Diseases and Emergency Preparedness Annual Report TABLE OF CONTENTS Section I. Introduction ...................................................................................................................................................... 1 A. Purpose of Report ...................................................................................................................................... 2 B. Notifiable Diseases in Tennessee .............................................................................................................. 2 C. Reporting Notifiable Diseases ................................................................................................................... 3 D. List of Notifiable Diseases ......................................................................................................................... 4 E. Isolate Characterization at the State Laboratory ...................................................................................... 6 F. Referral of Cultures or Positive Specimens to the Department of Health .............................................. 6 G. Tennessee Department of Health Regions ............................................................................................... 7 H. Useful Contact Persons, Telephone Numbers, E-Mail and U.S. Addresses ........................................... 7 I. Emerging Infections and the Emerging Infections Program .................................................................... 8 J. Communicable and Environmental Disease and Emergency Preparedness Website ............................. 9 K. Tennessee Population Estimates, 2012................................................................................................... 10 L. Tennessee’s Department of Health Regions: Counties and Population, 2012 ..................................... 10 M. Notes on Sources Used in Preparing the Annual Report ...................................................................... 12 Section II. Tennessee Reported Cases, 2003-2012 .......................................................................................................... 14 Reported Cases, by Year of Diagnosis, Tennessee, 2003-2012....................................................................... 15 Numbers of Reported Cases of Selected Notifiable Diseases with Rates per 100,000 Persons, by Age Group, Tennessee, 2012 ...................................................................................................................... 16 Section III. Disease Summaries .......................................................................................................................................... 18 A. Foodborne and Waterborne Diseases ..................................................................................................... 19 Tennessee FoodNet and FoodCORE Programs..................................................................................... 20 Campylobacteriosis ......................................................................................................................... 21 Listeriosis ......................................................................................................................................... 23 Salmonellosis ................................................................................................................................... 23 Shiga-toxin Producing E. coli and Hemolytic Uremic Syndrome .................................................. 25 Shigellosis ........................................................................................................................................ 26 Vibriosis and Cholera ..................................................................................................................... 27 Yersiniosis ........................................................................................................................................ 28 Foodborne and Waterborne Parasitic Diseases ...................................................................................... 28 Cryptosporidiosis ............................................................................................................................ 29 Cyclosporiasis .................................................................................................................................. 30 Foodborne Outbreaks ..................................................................................................................... 31 v Communicable and Environmental Diseases and Emergency Preparedness Annual Report TABLE OF CONTENTS (CONTINUED) B. Invasive Diseases ...................................................................................................................................... 33 Active Bacterial Core Surveillance (ABCs) ............................................................................................. 34 Other EIP Surveillance Activities ............................................................................................................ 35 Invasive Group A Streptococcal Disease ................................................................................................ 35 Invasive Group B Streptococcal Disease ................................................................................................. 37 Meningococcal Disease ............................................................................................................................ 38 Methicillin Resistant Staphylococcus aureus Invasive Disease—Passive Surveillance ................................ 39 Streptococcus pneumoniae Invasive Disease ................................................................................................ 40 C. Hepatitis ................................................................................................................................................... 43 Hepatitis A ............................................................................................................................................... 44 Perinatal Hepatitis B ................................................................................................................................ 45 Acute Hepatitis B Virus Infection .......................................................................................................... 45 Hepatitis C Virus ..................................................................................................................................... 47 D. Vaccine-Preventable Diseases .................................................................................................................. 49 Pertussis .................................................................................................................................................... 51 Tetanus ..................................................................................................................................................... 52 Influenza .................................................................................................................................................. 53 E. Vectorborne and Zoonotic Diseases ...................................................................................................... 55 Arboviral Diseases .................................................................................................................................... 56 LaCrosse Encephalitis (LAC) ........................................................................................................ 56 West Nile Fever/Encephalitis ......................................................................................................... 57 Malaria ............................................................................................................................................. 58 Tickborne Diseases ................................................................................................................................ 59 Ehrlichiosis ...................................................................................................................................... 59 Lyme Disease ..................................................................................................................................